Summary A consecutive series of 644 women who presented with breast nodularity between 1976 
Cystic disease of the breast is the most common benign disorder of the breast (Haagensen, 1971) , exceeded only by carcinoma in frequency.
Seven per cent of women in the Western World will have a cyst aspirated in their lifetime, but microcystic change on histology is much more common as in 58% of women undergoing breast biopsy (Page et al., 1978) and 23% of women at postmortem (Dupont & Page, 1985) were found to have cystic change. In 1971, Haagensen reported a 4-fold increased risk of breast cancer in women who had undergone cyst aspiration (Haagensen, 1971) but recently two large retrospective studies of patients undergoing breast biopsy for benign disease failed to find any increased relative risk for women who had cystic disease seen only in histological review. (Page et al., 1978; Dupont & Page, 1985) . The authors found that only women with histological evidence of proliferative disease (florid epithelial hyperplasia with or without atypia) have an increased risk of breast cancer. (Dupont & Page, 1985 
Discussion
The detailed pathological work of Page and Dupont (Page et al., 1978; Dupont & Page, 1985) was widely seen as disproving Haagensen's findings that women who had breast cysts were at an increased risk of breast cancer (Haagensen, 1971) . Page and Dupont's study was a histological retrospective review of 10,542 breast biopsies from 3,303 women who were followed up for a mean of 17 years and florid epithelial hyperplasia with or without atypia was the only histological risk factor for subsequent breast cancer development. Their Florid epitheliosis: Multiple cysts vs nodularity. Test for trend P <0.01. aFive patients developed breast cancer in the women who underwent biopsy and their biopsies all showed apocrine metaplasia but with varying degrees of co-existing hyperplasia.
incidence of gross cysts on histology was 23% and postmortem studies suggest an even higher incidence (Davies et al., 1964) yet it is estimated that only 7% of women in the Western world will develop a clinically aspirable breast cyst in their lifetime (Haagensen, 1971) . No information is available on the clinical cyst aspiration rate in the Page and Dupont paper. Modern practice is to aspirate breast cysts and histology is rarely available in contrast to the older series (Page et al., 1978; Dupont & Page, 1985; Davies et al., 1964) and thus direct comparison between studies is difficult. Haagensen's original finding of an increased breast cancer risk in women who have had aspiration of a breast cyst has been sustained in this study. Two other clinical studies of breast cancer risk following cyst aspiration have reached similar conclusions (Jones & Bradbeer, 1980; Harrington & Lesnick, 1981) . This study is based on patients with aspirated cysts and confirms the previous work (Jones & Bradbeer, 1980; Harrington & Lesnick, 1987 & Haagensen, 1971 , but additionally our histological data confirms that florid epithelial hyperplasia with or without atypia is the most important histological risk factor for subsequent breast cancer as did Dupont and Page. Histological macrocysts were common in both groups of women who had been biopsied, but were not a risk factor for subsequent breast cancer unlike clinically palpable cysts. Additionally, women who had undergone multiple cysts aspirations had the highest cancer risk clinically. Thus the best clinical marker for predicting breast cancer risk, multiple cysts, is significantly associated with underlying florid epithelial hyperplasia, the best histological risk marker. This may partly explain the apparent difference in risk of breast cancer between previous clinical and histological studies.
This study showed no increased risk of breast cancer for women who attended the breast clinic with benign nodularity without having a cyst aspirated (generally known as fibrocystic disease) unlike an earlier Cardiff study (Roberts et al., 1984) . The excess risk observed in this study is greater than previously reported (Haagensen, 1971; Jones & Bradbeer 1980; Harrington & Lesnick, 1981; Roberts et al., 1984) but other studies have not analysed risk for aspirated cysts separately from biopsy or mammographically proven cysts.
Women with benign nodularity in this study include a group of women with biopsy proven microcystic disease yet they had no increased risk. We must therefore postulate that palpable aspirable cysts are markers of underlying proliferative breast disease and carry a risk in excess of those women with histological microcyst formation, with multiple and bilateral palpable cysts carrying the highest risk. This finding supports our belief that macrocysts should be regarded simply as a normal involutional phenomen (Hughes et al., 1987) whereas cysts that become clinically evident represent real disease.
Although a relative risk of 4.4 times normal appears high it represents only 14 cases in a population of 352 women followed for an average of over 7 years. The majority of the 188 women with multiple cysts were under continued surveillance and had a heightened awareness of the importance of self-examination in which they were well practised (Roberts et al., 1984) .
Current surgical practice is to discharge most women who have cysts aspirated from follow-up once they stop forming new cysts. As we have demonstrated an increased risk of breast cancer in this group, a case could be made for continued follow-up but the workload of a surgical outpatients clinic would be significantly increased. A better approach would be to define further sub-groups within the multiple cyst group of women at the highest risk who could then be followed more closely. Possibilities under study include cyst electrolyte analysis (Miller et al., 1983) , or serial cyst protein analysis (Haagensen et al., 1979) . Another approach would be to suppress cyst formation by drug therapy. Danazol therapy is reported to reduce the number of frequency of new cysts (Dhont et al., 1979) but it is not known whether such therapy has any effect on cancer risk.
Several factors have been shown to be associated with an increased risk of subsequent breast cancer and women who have cysts aspirated should be encouraged to undertake breast self-examination to detect early reappearance of cysts and aid early diagnosis of any cancer that develops.
